Clinical Trial Update: Drug- Eluting Stent for Symptomatic Intracranial Arterial Stenosis [Phase 3]

View source ↗

Summary

Phase 3 trial update for a drug-eluting stent targeting symptomatic intracranial atherosclerotic stenosis. The study is currently recruiting in Beijing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Intracranial Atherosclerotic Stenosis

Drugs mentioned

• Drug-eluting stent (drug-eluting stent)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Symptomatic Intracranial Atherosclerotic Stenosis | Phase 3 | Status: RECRUITING